HSPA9 and ovarian cancer: Tissue microarray analyses suggested Mortalin (HSP70)-positive tumor cells exhibit the increased resistance against cisplatin, and silencing Mortalin with shRNA enhanced the drug sensitivity to cisplatin and reduced the tumor cell growth in ovarian cancer [109].